biote Corp. (BTMD)

↓ Download CSV

CIK 0001819253 · Nasdaq · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, biote Corp. reported revenue of $192.22M, down 2.5% from the prior year. The company was profitable, with a net margin of 14.1%. It held $107.61M in total assets against $158.01M in total liabilities.

Key ratios (FY2025)

18.5%
Operating margin
14.1%
Net margin
-2.5%
Revenue growth (YoY)
Metric (FY)202520242023202220212020
Revenue$192.22M$197.19M$185.36M$164.96M$139.40M
Operating Income$35.55M$31.61M$28.66M-$60.72M$34.56M
Net Income$27.05M$3.16M$3.32M-$969.0K$11.11M
EPS (Diluted)$0.74$0.09$0.13$-0.12
Total Assets$107.61M$122.37M$155.29M$111.64M$54.33M$147.5K
Total Liabilities$158.01M$224.57M$191.84M$169.92M$50.20M$122.5K
Shareholders' Equity-$58.54M-$105.93M-$29.40M-$44.46M$4.12M$25.0K
Cash & Equivalents$24.12M$39.34M$89.00M$79.23M$130.4K$1.6K
Operating Cash Flow$35.19M$45.24M$26.88M-$9.16M$33.72M
Capital Expenditures$5.01M$6.43M$359.0K$333.0K$1.45M
Shares Outstanding36.67M34.27M25.71M8.06M